Why Pro-Dex, Inc.’s (PDEX) Stock Is Down 5.36%
As of Wednesday, July 22, Pro-Dex, Inc.’s PDEX share price has dipped by 5.36%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Commentary & Analysis
Why Pro-Dex, Inc.’s (PDEX) Stock Is Down 8.90%
As of Monday, June 29, Pro-Dex, Inc.’s PDEX share price has dipped by 8.90%, which has investors questioning if this is right time to buy.Michael Rose
Why Pro-Dex, Inc.’s (PDEX) Stock Is Up 5.68%
As of Friday, May 08, Pro-Dex, Inc.’s PDEX share price has surged by 5.68%, which has investors questioning if this is right time to sell.Michael Rose
Why Pro-Dex, Inc.’s (PDEX) Stock Is Up 7.31%
As of Tuesday, May 05, Pro-Dex, Inc.’s PDEX share price has surged by 7.31%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Pro-Dex, Inc.’s (PDEX) Stock Is Down 12.41%
As of Friday, May 01, Pro-Dex, Inc.’s PDEX share price has dipped by 12.41%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | PDEX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $187.7 | $337.2 | 27% |
|
| Shares Out (Mil) | 3.3 | 41.9 | 11% |
|
| Institutional Ownership | 74.3% | 77.8% | 45% |
|
| Float (Mil) | 1.7 | 34.7 | 4% |
|
| Beta | -0.11 | 0.85 | 4% |
|
| Avg Daily Volume (000s) | 87 | 278 | 34% |
|
| Price Change (52-week) |
16.9% | 58.7% | 59% |
|
| Growth | PDEX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 13.9% | 11.8% | 70% |
|
| Net Income (5yr) | 8.1% | (5.8%) | 52% |
|
| EPS (5yr) | 12.2% | 11.4% | 50 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (14.5%) | (16.3%) | 55% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | 1 | 1 | |
| Current EPS | na | $3.940 | $2.780 | |
| Month Ago EPS | na | $3.940 | $2.780 | |
| # Rev Up | na | 1 | na | |
| # Rev Down | na | 0 | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | 47.6% | na | |
| Financials | PDEX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $75 | $152 | 24% |
|
| Net Income (TTM) (Mil) | $12 | ($10) | 47% |
|
| EPS (TTM) | $3.700 | ($0.500) | 82% |
|
| Operating Cash Flow (TTM) (Mil) | $7 | ($2) | 37% |
|
| Net Cash Flow (TTM) (Mil) | $6 | $1 | 54% |
|
| Long-Term Debt (Q1) (Mil) | $15 | $22 | 31% |
|
| Enterprise Value (Q1) (Mil) | $198 | $304 | 26% |
|
| Valuation | PDEX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.16 | 2.80 | 74% |
|
| P/E | 16.2 | 31.1 | 40% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 1.3 | 1.9 | 55% |
|
| Ratios | PDEX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 27.8% | 59.1% | 32% |
|
| Net Margin | 16.1% | (7.3%) | 75% |
|
| ROA | 17.2% | (13.7%) | 95% |
|
| ROE | 29.8% | (15.8%) | 87% |
|
| Liabilities to Assets | 39.7% | 44.7% | 30% |
|
| F-Score | 5 | 4 | 51% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Muhlenkamp Screen
Factors: Value, Quality, Growth
Muhlenkamp uses a bottom-up approach to selecting stocks, but adjusts his benchmarks based upon the broad economic environment.
| Performance Since Inception: | 6.2% |
| +/- S&P 500: | -1.3 |
FACTOR STRATEGY
Return on Equity Screen
Factors: Quality, Growth
A screen that identifies stocks with above average earnings and sales growth that have consistently outperformed their peers measured by ROE.
| Performance Since Inception: | 13.1% |
| +/- S&P 500: | +5.6 |
